Cargando…
Nature Biotechnology’s academic spinouts 2021
Nature Biotechnology’s annual survey highlights academic startups that are, among other things, designing circular RNA therapeutics, tackling cancer with arenaviruses, creating psychedelics without the trip, editing genes and cells in vivo, harnessing the power of autoantibodies and editing the epig...
Autores principales: | Eisenstein, Michael, Garber, Ken, Landhuis, Esther, DeFrancesco, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633025/ https://www.ncbi.nlm.nih.gov/pubmed/36329325 http://dx.doi.org/10.1038/s41587-022-01530-9 |
Ejemplares similares
-
A singular view of COVID-19
por: Eisenstein, Michael
Publicado: (2020) -
Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy()
por: Aguilar, Alfredo, et al.
Publicado: (2013) -
Expanding roles for academic entrepreneurship in drug discovery
por: Kinch, Michael S., et al.
Publicado: (2020) -
Complete 180-Degree Dislocation of a Rotating Platform after Closed Reduction for Mobile Bearing Spinout
por: Sommi, Corinne, et al.
Publicado: (2020) -
Iris Antes 1969–2021
por: Kapurniotu, Aphrodite, et al.
Publicado: (2022)